Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Chim Acta. 2010 Jul 4;411(13-14):984-91. doi: 10.1016/j.cca.2010.03.028. Epub 2010 Mar 30.

Proteomics-based identification of haptoglobin as a novel plasma biomarker in oral squamous cell carcinoma.

Author information

1
Department of Microbiology, School of Medicine, China Medical University, Taichung, Taiwan.

Abstract

BACKGROUND:

Identification of tumor biomarkers to assist early diagnosis and monitoring of disease progression may potentially decrease the mortality and morbidity associated with oral cancer.

METHODS:

A mouse model with oral squamous cell carcinoma (OSCC) induced by 4-nitroquinoline 1-oxide (4-NQO)/arecoline in drinking water was established to discover stage-associated biomarkers. A proteomics approach, immunoblot and immunohistochemical analysis were used to validate the expressed biomarkers in mice with OSCC. Human plasma samples were also collected and candidate biomarkers were evaluated using enzyme-linked immunosorbent assay.

RESULTS:

Proteomic profiling of mouse plasma samples indicated that haptoglobin and apolipoprotein A1 precursor were up-regulated in the mice with OSCC. Immunoblotting of plasma samples and immunohistochemical analysis of oral tissues showed a significantly higher level of haptoglobin in the OSCC mice than in the control mice. The expression of haptoglobin in human plasma samples from 52 patients with OSCC indicated a strong correlation between the increasing levels of haptoglobin and the clinical stages of OSCC (P<0.01).

CONCLUSIONS:

These results suggest that haptoglobin has a great potential as a sensitive plasma biomarker for early detection of patients with OSCC.

PMID:
20359475
DOI:
10.1016/j.cca.2010.03.028
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center